ARTICLE | Company News
Telesta, BL&H deal
August 24, 2015 7:00 AM UTC
Telesta granted BL&H exclusive rights to commercialize MCNA in South Korea. In June, Telesta submitted a BLA to FDA for the mycobacterial cell wall-DNA complex (MCC) to treat high-risk non-muscle inv...